A recent study conducted at Mayo Clinic and the University of Minnesota, as part of the Minnesota Partnership for Biotechnology and Medical Genomics, has identified pathways that allow doctors to look at biomarkers in the bloodstream to identify disease activity and flare.
Get the full story...
